Jeena Sikho Lifecare Limited
Jeena Sikho Lifecare Limited was a SME-platform initial public offer.
The book was open from 30 March 2022 to 7 April 2022.
The issue was priced at ₹566 a share.
We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.
The shares listed on 11 August 2025.
We hold price bars for this ISIN but none on or after its listing date, so nothing can be said about how the issue itself has done.
The exchange’s record for an issue of this vintage carries the price and the dates only — lot size, issue size and the fresh-versus-offer-for-sale split were not published in the feed. The offer documents below are the source for those.
- Bidding opens30 Mar 2022
- Bidding closes7 Apr 2022
- Basis of allotmentnot published
Not published in the exchange feeds we ingest — we do not estimate it.
- Listing11 Aug 2025
We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.
We did not poll this issue while its book was open. The exchange publishes only the current cumulative figure and no history, so a subscription series cannot be reconstructed after an issue closes.
We have not extracted an anchor allotment list for this issue.
- All other pre-issue capitalSEBI ICDR 2018 Reg. 17 — all other pre-issue capital, 6 months from allotment11 Feb 2026already free
- Promoters' minimum contributionSEBI ICDR 2018 Reg. 16(1)(a) — promoters' minimum contribution, 18 months from allotment11 Feb 2027whole tranche releases on this date
Computed from the SEBI ICDR 2018 lock-in rules, not disclosed by the issuer or the exchange. The regulation counts from the date of allotment, which no feed we ingest publishes, so these are counted from the listing date and fall at most two to three business days later than the true expiry.
The "Basis for Offer Price" chapter states the earnings the price was set against and the multiples it implies. We have not extracted it for this issue — several offer documents are served as .zip archives or as scanned pages with no text layer.
We have not extracted this section from the offer document for this issue yet. It is read from the abridged prospectus, and several offer documents are served as .zip archives or as scanned pages with no text layer.
We have not extracted this section from the offer document for this issue yet. It is read from the abridged prospectus, and several offer documents are served as .zip archives or as scanned pages with no text layer.
The offer document must name the listed companies the issuer considers comparable, and print their valuation figures beside its own. This is that list — the issuer’s choice of comparison, not ours.
| Company | P/E | P/B | RoNW | EPS | Income |
|---|---|---|---|---|---|
| Kerala Ayurveda Ltdnot in our universe | -11.7 | — | -49.3% | — | — |
The issuer's own figures as printed at the head of the same table — its claim about itself, on the same basis as its claims about the companies below.
Figures as PRINTED by the issuer in its own offer document. The comparison set is the issuer's choice, not ours.
No lead manager or registrar is recorded against this issue.
- Prospectus· PDF · exchange archive24 Mar 2022
- Draft red herring prospectus (DRHP)· PDF · exchange archive24 Feb 2022
- Draft red herring prospectus (DRHP)· PDF · exchange archive30 Sept 2021
Filed with SEBI and the exchanges by the issuer. These are the source for every figure on this page.
Compiled from NSE and SEBI offer documents and exchange feeds. A description of the issue and of the bids received — not investment advice, and not a view on whether to apply. No grey-market premium, no allotment lookup and no listing-gain estimate is published here.